118 related articles for article (PubMed ID: 8337438)
21. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
22. [Magnetic resonance imaging of the adrenal gland].
Ogita M; Oyama T; Onohara S; Nakabeppu Y; Mukai H; Abeyama K; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Dec; 51(12):1431-41. PubMed ID: 1792151
[TBL] [Abstract][Full Text] [Related]
23. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
Takano A; Oriuchi N; Tsushima Y; Taketomi-Takahashi A; Nakajima T; Arisaka Y; Higuchi T; Amanuma M; Endo K
Ann Nucl Med; 2008 Jun; 22(5):395-401. PubMed ID: 18600417
[TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
25. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
Shimizu A; Ito K; Sasaki K; Hayashida M; Tanabe M; Shimizu K; Matsunaga N
Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
[TBL] [Abstract][Full Text] [Related]
26. Adrenal masses: characterization with T1-weighted MR imaging.
Chezmar JL; Robbins SM; Nelson RC; Steinberg HV; Torres WE; Bernardino ME
Radiology; 1988 Feb; 166(2):357-9. PubMed ID: 3336711
[TBL] [Abstract][Full Text] [Related]
27. Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria.
Autti T; Lönnqvist T; Joensuu R
Acta Radiol; 2008 Jul; 49(6):687-92. PubMed ID: 18568562
[TBL] [Abstract][Full Text] [Related]
28. Malignant melanoma of the sinonasal cavity: explanation of magnetic resonance signal intensities with histopathologic characteristics.
Kim SS; Han MH; Kim JE; Lee CH; Chung HW; Lee JS; Chang KH
Am J Otolaryngol; 2000; 21(6):366-78. PubMed ID: 11115521
[TBL] [Abstract][Full Text] [Related]
29. [Magnetic resonance in thoracic pathology: characterization by intensity values].
Carriero A; Severini S; Samuele F; D'Arcangelo M; Iarussi T; Bonomo L
Radiol Med; 1994; 88(1-2):31-5. PubMed ID: 8066252
[TBL] [Abstract][Full Text] [Related]
30. Differential diagnosis of adrenal masses using out-of-phase FLASH imaging. A preliminary report.
Tsushima Y; Ishizaka H; Kato T; Matsumoto M
Acta Radiol; 1992 May; 33(3):262-5. PubMed ID: 1591131
[TBL] [Abstract][Full Text] [Related]
31. MR evaluation of adrenal masses at 1.5 T.
Baker ME; Blinder R; Spritzer C; Leight GS; Herfkens RJ; Dunnick NR
AJR Am J Roentgenol; 1989 Aug; 153(2):307-12. PubMed ID: 2750617
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Versus Qualitative Methods in Evaluation of T2 Signal Intensity to Improve Accuracy in Diagnosis of Pheochromocytoma.
Borhani AA; Hosseinzadeh K
AJR Am J Roentgenol; 2015 Aug; 205(2):302-10. PubMed ID: 26204279
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease.
Falaschi F; Battolla L; Mascalchi M; Cioni R; Zampa V; Lencioni R; Antonelli A; Bartolozzi C
AJR Am J Roentgenol; 1996 Apr; 166(4):963-8. PubMed ID: 8610582
[TBL] [Abstract][Full Text] [Related]
34. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging.
Outwater EK; Siegelman ES; Radecki PD; Piccoli CW; Mitchell DG
AJR Am J Roentgenol; 1995 Sep; 165(3):579-83. PubMed ID: 7645474
[TBL] [Abstract][Full Text] [Related]
35. Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow.
Zajick DC; Morrison WB; Schweitzer ME; Parellada JA; Carrino JA
Radiology; 2005 Nov; 237(2):590-6. PubMed ID: 16244268
[TBL] [Abstract][Full Text] [Related]
36. MR characterization of adrenal masses: field strength and pulse sequence considerations.
Kier R; McCarthy S
Radiology; 1989 Jun; 171(3):671-4. PubMed ID: 2717736
[TBL] [Abstract][Full Text] [Related]
37. Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.
Suh I; Shibru D; Eisenhofer G; Pacak K; Duh QY; Clark OH; Kebebew E
Ann Surg; 2009 Dec; 250(6):983-90. PubMed ID: 19661783
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of adrenal masses with MR imaging: comparison of techniques.
Reinig JW; Stutley JE; Leonhardt CM; Spicer KM; Margolis M; Caldwell CB
Radiology; 1994 Jul; 192(1):41-6. PubMed ID: 8208962
[TBL] [Abstract][Full Text] [Related]
39. Bladder paraganglioma in adults: MR appearance in four patients.
Wang H; Ye H; Guo A; Wei Z; Zhang X; Zhong Y; Fan Z; Wang Y; Wang D
Eur J Radiol; 2011 Dec; 80(3):e217-20. PubMed ID: 20950973
[TBL] [Abstract][Full Text] [Related]
40. Multimodality imaging findings of pheochromocytoma with associated clinical and biochemical features in 53 patients with histologically confirmed tumors.
Raja A; Leung K; Stamm M; Girgis S; Low G
AJR Am J Roentgenol; 2013 Oct; 201(4):825-33. PubMed ID: 24059371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
